Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000544902 | SCV000636841 | likely benign | Schimke immuno-osseous dysplasia | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000593130 | SCV000703955 | uncertain significance | not provided | 2017-01-09 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000544902 | SCV000898989 | uncertain significance | Schimke immuno-osseous dysplasia | 2021-03-30 | criteria provided, single submitter | clinical testing | SMARCAL1 NM_014140.3 exon 11 c.1851+5G>A: This variant has not been reported in the literature but is present in 0.3% (84/24022) of African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/2-217311886-G-A). This variant is present in ClinVar (Variation ID:463146). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is an intronic variant; splice prediction tools are unclear whether this variant may or may not affect splicing. Further studies are needed to understand its impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Prevention |
RCV003960300 | SCV004767677 | likely benign | SMARCAL1-related disorder | 2021-03-25 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV000544902 | SCV001455765 | likely benign | Schimke immuno-osseous dysplasia | 2020-09-16 | no assertion criteria provided | clinical testing |